3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 9987446 |
SCHEMBL ID | 487075 |
MeSH ID | M0129648 |
Synonym |
---|
7207-68-3 |
5-fluoro-2'-deoxy-o',o'-dipalmitoyluridine |
uridine, 2'-deoxy-5-fluoro-, 3',5'-dihexadecanoate |
3',5'-o-dipalmitoyl-5-fluoro-2'-deoxyuridine |
3,5-dipalmitoyl-fudr |
2'-deoxy-3',5'-di-o-palmitoyl-5-fluorouridine |
BJLOKZVEONMGKJ-HKIDPNTFSA-N |
SCHEMBL487075 |
[(2r,3s,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3-hexadecanoyloxyoxolan-2-yl]methyl hexadecanoate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.91) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |